Capacity to make medical treatment decisions in multiple sclerosis: A potentially remediable deficit

Michael R. Basso, Philip J. Candilis, Jay Johnson, Courtney Ghormley, Dennis R. Combs, Taeh Ward

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Ability to make decisions about medical treatment is compromised in significant numbers of people with neurological and psychiatric illness, and this incapacity frequently corresponds with compromised neuropsychological function. Although cognitive deficits occur often in people with multiple sclerosis (MS), no research has studied decisional capacity in that disease. The present investigation examined ability to understand treatment disclosures, which is a core component of decisional capacity, in 36 people with MS and 16 normal controls. MS patients with diminished neuropsychological function showed poor understanding of treatment disclosures compared to the control group, and diminished new learning and executive function correlated with poorer understanding. Nonetheless, with sufficient cuing, the MS patients with diminished neuropsychological function were able to display understanding that was equivalent to that of the control group. Implications of these results for clinical practice and medical research involving people with MS are discussed.

Original languageEnglish
Pages (from-to)1050-1061
Number of pages12
JournalJournal of Clinical and Experimental Neuropsychology
Volume32
Issue number10
DOIs
StatePublished - 1 Dec 2010

Fingerprint

Multiple Sclerosis
Aptitude
Disclosure
Therapeutics
Control Groups
Executive Function
Psychiatry
Biomedical Research
Learning
Research

Keywords

  • Decision making
  • Informed consent
  • Multiple sclerosis
  • Neuropsychological function

Cite this

Basso, Michael R. ; Candilis, Philip J. ; Johnson, Jay ; Ghormley, Courtney ; Combs, Dennis R. ; Ward, Taeh. / Capacity to make medical treatment decisions in multiple sclerosis : A potentially remediable deficit. In: Journal of Clinical and Experimental Neuropsychology. 2010 ; Vol. 32, No. 10. pp. 1050-1061.
@article{665b1d39d87e4c08ac3b45a816a699e8,
title = "Capacity to make medical treatment decisions in multiple sclerosis: A potentially remediable deficit",
abstract = "Ability to make decisions about medical treatment is compromised in significant numbers of people with neurological and psychiatric illness, and this incapacity frequently corresponds with compromised neuropsychological function. Although cognitive deficits occur often in people with multiple sclerosis (MS), no research has studied decisional capacity in that disease. The present investigation examined ability to understand treatment disclosures, which is a core component of decisional capacity, in 36 people with MS and 16 normal controls. MS patients with diminished neuropsychological function showed poor understanding of treatment disclosures compared to the control group, and diminished new learning and executive function correlated with poorer understanding. Nonetheless, with sufficient cuing, the MS patients with diminished neuropsychological function were able to display understanding that was equivalent to that of the control group. Implications of these results for clinical practice and medical research involving people with MS are discussed.",
keywords = "Decision making, Informed consent, Multiple sclerosis, Neuropsychological function",
author = "Basso, {Michael R.} and Candilis, {Philip J.} and Jay Johnson and Courtney Ghormley and Combs, {Dennis R.} and Taeh Ward",
year = "2010",
month = "12",
day = "1",
doi = "10.1080/13803391003683062",
language = "English",
volume = "32",
pages = "1050--1061",
journal = "Journal of Clinical and Experimental Neuropsychology",
issn = "1380-3395",
publisher = "Taylor and Francis Ltd.",
number = "10",

}

Capacity to make medical treatment decisions in multiple sclerosis : A potentially remediable deficit. / Basso, Michael R.; Candilis, Philip J.; Johnson, Jay; Ghormley, Courtney; Combs, Dennis R.; Ward, Taeh.

In: Journal of Clinical and Experimental Neuropsychology, Vol. 32, No. 10, 01.12.2010, p. 1050-1061.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Capacity to make medical treatment decisions in multiple sclerosis

T2 - A potentially remediable deficit

AU - Basso, Michael R.

AU - Candilis, Philip J.

AU - Johnson, Jay

AU - Ghormley, Courtney

AU - Combs, Dennis R.

AU - Ward, Taeh

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Ability to make decisions about medical treatment is compromised in significant numbers of people with neurological and psychiatric illness, and this incapacity frequently corresponds with compromised neuropsychological function. Although cognitive deficits occur often in people with multiple sclerosis (MS), no research has studied decisional capacity in that disease. The present investigation examined ability to understand treatment disclosures, which is a core component of decisional capacity, in 36 people with MS and 16 normal controls. MS patients with diminished neuropsychological function showed poor understanding of treatment disclosures compared to the control group, and diminished new learning and executive function correlated with poorer understanding. Nonetheless, with sufficient cuing, the MS patients with diminished neuropsychological function were able to display understanding that was equivalent to that of the control group. Implications of these results for clinical practice and medical research involving people with MS are discussed.

AB - Ability to make decisions about medical treatment is compromised in significant numbers of people with neurological and psychiatric illness, and this incapacity frequently corresponds with compromised neuropsychological function. Although cognitive deficits occur often in people with multiple sclerosis (MS), no research has studied decisional capacity in that disease. The present investigation examined ability to understand treatment disclosures, which is a core component of decisional capacity, in 36 people with MS and 16 normal controls. MS patients with diminished neuropsychological function showed poor understanding of treatment disclosures compared to the control group, and diminished new learning and executive function correlated with poorer understanding. Nonetheless, with sufficient cuing, the MS patients with diminished neuropsychological function were able to display understanding that was equivalent to that of the control group. Implications of these results for clinical practice and medical research involving people with MS are discussed.

KW - Decision making

KW - Informed consent

KW - Multiple sclerosis

KW - Neuropsychological function

UR - http://www.scopus.com/inward/record.url?scp=78650114016&partnerID=8YFLogxK

U2 - 10.1080/13803391003683062

DO - 10.1080/13803391003683062

M3 - Article

C2 - 20446143

AN - SCOPUS:78650114016

VL - 32

SP - 1050

EP - 1061

JO - Journal of Clinical and Experimental Neuropsychology

JF - Journal of Clinical and Experimental Neuropsychology

SN - 1380-3395

IS - 10

ER -